Management of localized and advanced prostate cancer in Canada: A lifetime cost and quality-adjusted life-year analysis-Reference-Cited by-同舟云学术

Management of localized and advanced prostate cancer in Canada: A lifetime cost and quality-adjusted life-year analysis

Published:2016-02-01 Issue:7 Volume:122 Page:1085-1096
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Sanyal Chiranjeev¹,Aprikian Armen G.¹²,Cury Fabio L.¹³,Chevalier Simone¹²,Dragomir Alice¹²

Affiliation:

1. Department of Urology; McGill University; Montreal Quebec Canada

2. Research Institute of McGill University Health Center; Montreal Quebec Canada

3. Division of Radiation Oncology; McGill University Health Center; Montreal Quebec Canada

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.29892/fullpdf

Reference51 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin.,2011

2. Cancer statistics, 2014;Siegel;CA Cancer J Clin.,2014

3. Canadian Cancer Society Canadian cancer statistics http://www.cancer.ca/en/cancer-information/cancer-101/canadian-cancer-statistics-publication/?region=on 2015

4. National Comprehensive Cancer Network NCCN guidelines http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site 2015

5. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013;Heidenreich;Eur Urol.,2014

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between exposure to parabens and benzophenones and prostate cancer risk in the EPIC-Spain cohort;Environmental Science and Pollution Research;2023-12-26

2. Relationship between exposure to parabens and benzophenones and prostate cancer risk in the EPIC-Spain cohort;2023-10-11

3. Analysis of active surveillance uptake for localized prostate cancer in Quebec in 2016: A Canadian bicentric study and comparison with 2010 data;Progrès en Urologie;2023-10

4. Minimal Residual Disease (MRD) and a New Immunotherapy in Locally Advanced Prostate Cancer;Interdisciplinary Cancer Research;2022

5. Novel therapeutic targets for cancer metastasis;Expert Review of Anticancer Therapy;2020-01-30